5-HT3 receptor antagonists come in a variety of formulations offering multiple routes of administration.

Some common dosing and administration regimens are as follows: (note, this list is not exhaustive)

- Ondansetron: 

- For nausea and vomiting prophylaxis, chemotherapy-related:

- IV: (moderately to highly emetogenic chemo): 0.15 mg/kg/dose every 4 hours for 3 doses, max 16 mg per dose. Start 30 minutes before chemo.
- PO: (highly emetogenic chemo): 24 mg once 30 minutes before chemo; do not cut or chew ODT dose forms.
- PO: (moderately emetogenic chemo): 8 mg every 8 hours for two doses, then 8 mg every 12 hours until one or two days following chemo completion. Start 30 minutes before chemo and do not cut, crush or chew ODT dosage forms.


- Nausea and vomiting prophylaxis, post-operative: 4 mg IM for one dose.
- Nausea and vomiting prophylaxis, X-ray therapy (XRT) related (total body): 8 mg PO for one dose, given 1 to 2 hours before each therapy fraction; do not cut, crush or chew ODT dosage forms.

- Granisetron:

- Nausea and vomiting prophylaxis, chemotherapy-related: 10 mg IV 30 minutes before chemo; oral dose within 1 hour before chemo. Alternately, 2 mg PO once or 1 mg PO every 12 hours for two doses.
- Nausea and vomiting prophylaxis, XRT-related: 2 mg orally for a single dose; start within one hour of XRT.
- Nausea and vomiting prophylaxis, post-operative: 1 mg IV for a single dose.

- Palonosetron:

- Nausea and vomiting prevention, chemo-related: 0.25 mg IV for one dose, started 30 minutes before chemo.
- Nausea and vomiting prophylaxis, post-operative: 0.075 mg IV for a single dose, started immediately prior to anesthesia induction.